InvestorsHub Logo
Followers 18
Posts 737
Boards Moderated 0
Alias Born 12/20/2017

Re: None

Thursday, 11/16/2023 8:08:34 AM

Thursday, November 16, 2023 8:08:34 AM

Post# of 70650
A raise in the Authorized must be included in a filing of an 8k or 10Q if you can find it then include the link and page number. There is no filing to raise the Authorized as of the latest 10Q filed on Nov 13 BRBL still has 100 billion authorized. Hate on it fine but just don't be that lying manipulator.
15. COMMON STOCK



On February 1, 2023, the Company filed a Certificate of Amendment with the Florida Secretary of State to increase the number of authorized common shares from 20,000,000,000 to 30,000,000,000 with a par value of $0.0001.



On February 27, 2023, the Company filed a Certificate of Amendment with the Florida Secretary of State to increase the number of authorized common shares from 30,000,000,000 to 100,000,000,000 with a par value of $0.0001.



During the nine months ended September 30, 2023, 68,296,141 shares of common stock were purchased for $24,203 pursuant to an Equity Purchase Agreement.



During the nine months ended September 30, 2023, 1,976 shares of Convertible Series A Preferred stock, valued at $530,556, were converted into 2,010,402,290 common shares in accordance with the conversion terms. The issuances resulted in a loss on conversion of $30,530, which was recorded to the statement of operations.



During the nine months ended September 30, 2023, Jef Lewis converted 1,211 Series A Convertible Preferred shares, valued at $325,153 in to 1,260,160,000 shares of common stock. The common stock was valued at $1,456,522 based on the market price on the date of the conversions, and the company recorded a loss on conversion of $1,131,369 to the statement of operations.

32


During the nine months ended September 30, 2023, Bennett Buchanan converted 689 Series A Convertible Preferred shares, valued at $184,997 into 1,849,965,000 shares of common stock. The common stock was valued at $554,990 based on the market price on the date of the conversion, and the company recorded a loss on conversion of $369,993 to the statement of operations.



During the nine months ended September 30, 2023, warrant holders exercised the warrants and the Company issued 73,800,000 shares of common stock through a cashless exercise of the warrants in accordance with the conversion terms. The issuance resulted in a loss on conversion of $22,066 and settled $117 worth of derivative liabilities which was recorded to additional paid-in capital.



During the nine months ended September 30, 2023, the holders of convertible notes converted a total of $570,079 of principal, interest, and fees into 3,368,396,834 shares of common stock in accordance with the conversion terms. The issuances resulted in a loss on conversion of $27,123 and settled $1,891,895 worth of derivative liabilities which was recorded to additional paid in capital.



As of September 30, 2023, 100,000,000,000 common shares, par value $0.0001, were authorized, of which 8,838,743,427 shares were issued and outstanding.

https://www.otcmarkets.com/filing/html?id=17050402&guid=p1J-kHOfTriG5Vh#BRBL-10Q_HTM_a003_v1